InvestorsObserver
×
News Home

Will Greenwich Lifesciences Inc (GLSI) Stay at the Bottom of the Healthcare Sector?

Friday, June 10, 2022 12:08 PM | InvestorsObserver Analysts

Mentioned in this article

Will Greenwich Lifesciences Inc (GLSI) Stay at the Bottom of the Healthcare Sector?

Greenwich Lifesciences Inc (GLSI) is around the middle of the Healthcare sector according to InvestorsObserver. GLSI received an overall rating of 40, which means that it scores higher than 40% of stocks. Additionally, Greenwich Lifesciences Inc scored a 36 in the Healthcare sector, ranking it higher than 36% of stocks in that sector.

Overall Score - 40
GLSI has an Overall Score of 40. Find out what this means to you and get the rest of the rankings on GLSI!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. *Investors Observer* allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 40 would rank higher than 40 percent of all stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Greenwich Lifesciences Inc Stock Today?

Greenwich Lifesciences Inc (GLSI) stock is trading at $8.95 as of 12:07 PM on Friday, Jun 10, a loss of -$1.57, or -14.92% from the previous closing price of $10.52. The stock has traded between $8.95 and $10.38 so far today. Volume today is high. So far 230,788 shares have traded compared to average volume of 170,092 shares. Click Here to get the full Stock Report for Greenwich Lifesciences Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App